1. Home
  2. Stocks
  3. Walpar Share Price

Walpar Nutritions Share Price

Pharmaceuticals Small Cap

₹51.10 +0.1 (0.2%)

05 Nov, 2024 16:51

SIP TrendupStart SIP in WALPAR

Start SIP
Performance Financial Technical Events FnO Shareholding Pattern More FAQ’s

Performance

  • Low
  • ₹51
  • High
  • ₹51
  • 52 Week Low
  • ₹39
  • 52 Week High
  • ₹77
  • Open Price₹51
  • Previous Close₹51
  • Volume2,000

Investment Returns

  • Over 1 Month + 4.93%
  • Over 3 Month -19.27%
  • Over 6 Month -22.04%
  • Over 1 Year + 23.88%
SIP Lightning

Smart Investing Starts Here Start SIP with Walpar Nutritions for Steady Growth!

Walpar Nutritions Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • PEG Ratio
  • Market Cap Cr
  • 48
  • P/B Ratio
  • 2.9
  • Average True Range
  • 2.42
  • EPS
  • 1.1
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.69
  • RSI
  • 50.88
  • MFI
  • 48.45

Walpar Nutritions Financial

IndicatorMar 24Mar 23
Revenue From Operations [Gross]51.3128.70
Revenue From Operations [Net]51.3128.70
Total Operating Revenues51.3128.70
Total Revenue51.4428.97
Total Expenses49.9628.51
Profit/Loss Before Tax1.480.46
Profit/Loss For The Period1.110.29
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity3.131.09
Net Cash Used In Investing Activity-0.880.46
Net Cash Used in Finance Activity-2.18-1.52
Net Inc/Dec In Cash And Equivalent0.070.03
Cash And Equivalent End Of Year0.450.37
IndicatorMar 24Mar 23
Total Share Capital4.704.54
Total Non-Current Liabilities0.001.03
Total Current Liabilities10.169.51
Total Capital And Liabilities23.4921.86
Total Non-Current Assets6.375.69
Total Current Assets17.1216.17
Total Assets23.4921.86
Indicator20242023
EBIT Margin (%)3.282.79
Return On Capital Employed (%)12.636.50
Return On Equity (%)8.332.60
Long Term Debt To Equity (%)0.009.06
Book Value/Share (INR)14.2012.46
IndicatorMar 24Mar 23
Revenue From Operations [Gross]62.5235.14
Revenue From Operations [Net]62.5235.14
Total Operating Revenues62.5235.14
Total Revenue62.7435.48
Total Expenses60.2534.35
Profit/Loss Before Tax2.491.11
Profit/Loss For The Period1.950.81
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity5.351.10
Net Cash Used In Investing Activity-3.61-3.44
Net Cash Used in Finance Activity-1.772.42
Net Inc/Dec In Cash And Equivalent-0.030.07
Cash And Equivalent End Of Year0.510.54
IndicatorMar 24Mar 23
Total Share Capital4.704.54
Total Non-Current Liabilities4.086.11
Total Current Liabilities16.6714.59
Total Capital And Liabilities37.1734.30
Total Non-Current Assets12.5310.71
Total Current Assets24.6323.59
Total Assets37.1734.30
Indicator20242023
EBIT Margin (%)5.055.46
Return On Capital Employed (%)15.429.74
Return On Equity (%)11.151.87
Long Term Debt To Equity (%)28.7452.17
Book Value/Share (INR)17.4914.97

Walpar Nutritions Technicals

EMA & SMA

Current Price
₹51.10
+ 0.1 (0.2%)
pointer
  • stock-down_img
  • Bullish Moving Average 9
  • stock-up_img
  • Bearish Moving Average 7
  • 20 Day
  • ₹49.89
  • 50 Day
  • ₹52.78
  • 100 Day
  • ₹54.69
  • 200 Day
  • ₹52.89

Resistance and Support

50.7 Pivot Speed
  • R3 52.20
  • R2 51.60
  • R1 51.30
  • S1 50.40
  • S2 49.80
  • S3 49.50

Is Walpar Nutritions Worth Buying?

BUY SELL HOLD

You can only vote for once

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Walpar Nutritions has an operating revenue of Rs. 130.49 Cr. on a trailing 12-month basis. An annual revenue growth of 77% is outstanding, Pre-tax margin of 4% needs improvement, ROE of 11% is good. The company has a reasonable debt to equity of 29%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 15 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 137 indicates it belongs to a poor industry group of Food-Misc Preparation and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Walpar Nutritions Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-07-05 Bonus issue
2024-05-27 Audited Results
2023-05-22 Audited Results
2022-11-14 Quarterly Results
2021-11-13 Quarterly Results
Date Purpose Remarks
2024-08-14 Bonus Rs.0.00 issue of equity shares in the ratio of 1:1 of Rs. 10/-.

Walpar Nutritions F&O

Walpar Nutritions Shareholding Pattern

68.44%
22.71%
8.85%
  • NSE Symbol
  • WALPAR
  • BSE Symbol
  • Managing Director
  • Mr. Kalpesh Ladhawala
  • ISIN
  • INE0G2G01015

Walpar Nutritions FAQs

Walpar Nutritions share price is ₹51 As on 05 November, 2024 | 16:37

The Market Cap of Walpar Nutritions is ₹48 Cr As on 05 November, 2024 | 16:37

The P/E ratio of Walpar Nutritions is As on 05 November, 2024 | 16:37

The PB ratio of Walpar Nutritions is 2.9 As on 05 November, 2024 | 16:37

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

The Vigilance Awareness Week for the year 2024 (VAW 2024) would be observed from October 28, 2024 to November 03, 2024
“सत्यनिष्ठा की संस्कृनि सेराष्र की समद्ृधि” “Culture of Integrity for Nation's Prosperity”
e-pledge link (https://pledge.cvc.nic.in/)

5paisa Capital Ltd. CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

*Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

Contact Us

Attention Investors

  • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
  • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
  • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Email: support@5paisa.com

Support Desk Helpline: 8976689766

©2024, 5paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.